|
MYO5C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.22480042669326E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69970000296615E-08 |
| Normal-vs-Stage2 |
4.36110000001655E-06 |
| Normal-vs-Stage3 |
7.79250000082499E-08 |
| Normal-vs-Stage4 |
8.39739999758393E-08 |
| Stage1-vs-Stage2 |
6.570000E-01 |
| Stage1-vs-Stage3 |
4.175400E-01 |
| Stage1-vs-Stage4 |
2.856600E-01 |
| Stage2-vs-Stage3 |
8.834800E-01 |
| Stage2-vs-Stage4 |
7.242600E-01 |
| Stage3-vs-Stage4 |
8.109600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.36569999753533E-08 |
| Normal-vs-AfricanAmerican |
4.593000E-04 |
| Normal-vs-Asian |
7.65600000000033E-05 |
| Caucasian-vs-AfricanAmerican |
9.506600E-01 |
| Caucasian-vs-Asian |
8.121600E-01 |
| AfricanAmerican-vs-Asian |
8.244000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.79880554895817E-11 |
| Normal-vs-Female |
2.03400000176046E-08 |
| Male-vs-Female |
2.125500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.09809999946509E-07 |
| Normal-vs-Age(41-60Yrs) |
3.6298000161139E-09 |
| Normal-vs-Age(61-80Yrs) |
5.35470001672422E-10 |
| Normal-vs-Age(81-100Yrs) |
2.563900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.636600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.623900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.022600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.729020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.906000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.526400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.978200E-01 |
| Classical-VS-Follicular |
6.585300E-04 |
| Classical-VS-Other |
2.325600E-01 |
| Classical-VS-Normal |
1.31970000039061E-07 |
| Tall-VS-Follicular |
4.606300E-02 |
| Tall-VS-Other |
2.646400E-01 |
| Tall-VS-Normal |
1.302960E-03 |
| Follicular-VS-Other |
9.555200E-01 |
| Follicular-VS-Normal |
1.39430023082809E-10 |
| Other-VS-Normal |
3.776500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.37019975763064E-10 |
| Normal-vs-N1 |
1.61114999999157E-05 |
| N0-vs-N1 |
4.951800E-01 |
|
|
